Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marc Kamin, MD
SK Life Science, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Theresa'S General Hospital
Hyderabad, Andhra Pradesh, India
- Bangalore Clinisearch
Bangalore, Karnataka, India
- M.S. Ramaiah Medical College and Hospital
Bangalore, Karnataka, India
- Mallikatta Neuro Centre
Mangalore, Karnataka, India
- Deenanath Mangeshkar Hospital & Research Centre
Pune, Maharashtra, India
- Max Super Specialty Hospital
Sāket, New Delhi, India
- Nightingale Hospital
Kolkata, West Bengal, India
- Nzoz Vito-Med Sp. Zo.O
Gliwice, Poland
- Nzoz Diagnomed
Katowice, Poland
- Spsk Nr 7 Sum W Katowicach, Gornoslaskie Cm Im. Prof. Leszka Gieca
Katowice, Poland
- Centrum Leczenia Padaczki I Migreny
Krakow, Poland
- Malopolskie Centrum Medyczne
Krakow, Poland
- Centrum Terapii Wspolczesnej
Lodz, Poland
- Solumed S.C.
Poznan, Poland
- Dong-A University Medical Center
Busan, South Korea
- Keimyung University Dongsan Hospital
Daegu, South Korea
- Chungnam National University Hospital
Daejeon, South Korea
- Hallym University Sacred Heart Hospital
Gyeonggi-do, South Korea
- Asan Medical Center
Seoul, South Korea
- Korea University Anam Hospital
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- St. Joseph Hospital & Medical Center/barrow Neurology Clinic
Phoenix, Arizona, United States
- Clinical Trials, Inc.
Little Rock, Arkansas, United States
- Kaiser Permanente
Anaheim, California, United States
- Va Greater Los Angeles Healthcare System
Los Angeles, California, United States
- Bradenton Research Center, Inc.
Bradenton, Florida, United States
- Bluegrass Epilepsy Research, Llc
Lexington, Kentucky, United States
- John'S Hopkins University School of Medicine
Baltimore, Maryland, United States
- Mid-Atlantic Epilepsy and Sleep Center
Bethesda, Maryland, United States
- Suite 209 South
Chesterfield, Missouri, United States
- Ohio State University Medical Center
Columbus, Ohio, United States
- the University of Toledo
Toledo, Ohio, United States
- Lynn Health Science Institute
Oklahoma City, Oklahoma, United States
- Thomas Jefferson University Comprehensive Epilepsy Center
Philadelphia, Pennsylvania, United States
- University of Pennsylvania Health System
Philadelphia, Pennsylvania, United States
- Neurological Clinic of Texas, P.A.
Dallas, Texas, United States
- University of Virginia
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Jul 2011
- Primary completion
- 30 Jun 2013
- Completion
- 28 Jan 2021
- Last update posted
- 11 Apr 2022
- Registered enrollment
- 222
- Registry id
- NCT01397968
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.